IPP Bureau
Glenmark posts 72.2% jump in Q2 FY net profit at Rs. 610.4 Cr YoY
By IPP Bureau - November 16, 2025
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr
By IPP Bureau - November 16, 2025
Total income for the period stood at Rs. 7101.28 crore
Medico Remedies gets GMP compliance certificate from SMDC, Ukraine
By IPP Bureau - November 16, 2025
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
Amcor launches ultra-light Shadow roll-on for next-gen beauty branding
By IPP Bureau - November 16, 2025
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
ALBIS unveils next-gen healthcare materials at COMPAMED 2025
By IPP Bureau - November 16, 2025
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Abbott unveils new diabetes care formula amid rising global diabetes crisis
By IPP Bureau - November 16, 2025
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
Cenmed and Curavit team up to revolutionize clinical trial logistics
By IPP Bureau - November 16, 2025
This collaboration turns kitting into a strategic advantage for sponsors and sites
ImmunoScape inks agreement with Cue Biopharma to launch next-gen cancer immunotherapy
By IPP Bureau - November 16, 2025
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Merck to acquire Cidara Therapeutics for $9.2 billion
By IPP Bureau - November 15, 2025
Diversifying its portfolio to include late-phase antiviral agent
Zydus receives final approval from USFDA for Leuprolide Acetate injection
By IPP Bureau - November 15, 2025
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities
By IPP Bureau - November 15, 2025
The observations are procedural in nature and will be responded to within the stipulated time
Caplin Point Laboratories’ subsidiary acquires land in Mexico
By IPP Bureau - November 15, 2025
The investment in land is Rs. 19.85 crore
Pfizer completes up to $10 billion acquisition of Metsera
By IPP Bureau - November 14, 2025
Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape
Zydus receives FDA final approval for Diroximel fumarate delayed-release capsules, 231 mg
By IPP Bureau - November 14, 2025
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
